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Abstract 
Objective: Asthma and anxiety are known to interact, leading to exacerbations for both 
conditions. This systematic review summarised evidence regarding the effectiveness of 
cognitive-behavioural therapy (CBT) in reducing anxiety for individuals with asthma, with 
results presented separately for adults and children. 
Data Sources: PRISMA statement and CRD guidance was followed to conduct and report the 
current review. Three major electronic databases (Ovid Medline, PsycINFO, and EMBASE) and 
manual searches were used to find relevant published and unpublished research. 
Study Selections: Sixteen trials (twelve adult and four child) met inclusion criteria, and were 
evaluated with adapted quality criteria. Both controlled trials and repeated-measure designs were 
eligible. All CBT intervention formats were eligible (group, individual, computerised, self-help). 
Nine studies (eight adult and one child) focused upon participants with either an anxiety 
condition diagnosis or above threshold anxiety scores on a validated measure of anxiety at 
baseline. 
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Results: The review indicates tentative preliminary support for the use of CBT for anxiety in 
adults with asthma, with the evidence-base for interventions with children appearing promising, 
but under-developed. Studies were more likely to indicate beneficial effects where anxiety-
focused (rather than illness-focused) intervention protocols were utilised, asthma-related 
education was provided and where the trials focused on individuals with likely clinical levels of 
anxiety at baseline. 
Conclusion: Whilst further high quality research is needed, available evidence is supportive of 
anxiety-focused CBT interventions tailored to target the particular mechanisms thought to 
maintain this comorbidity in asthma. 
Keywords 
anxiety, asthma, cognitive behavioural therapy, psychological interventions, systematic review, 
CBT, adults, children and adolescents 
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Introduction 
Asthma is the most common chronic health condition, affecting more than 300 million 
individuals worldwide [1], one fifth of which are children [2]. There are well-established links 
between asthma and anxiety conditions. A review of 15 studies reported an average prevalence 
of 34% of any anxiety disorder amongst adults with asthma, primarily panic attacks (25%) [3]. 
Children with asthma also experience a significantly higher risk of meeting criteria of several 
anxiety disorders, including separation anxiety, social anxiety, specific phobia, panic and 
generalised anxiety disorder [4,5]. 
Asthma attacks are particularly aversive, which can reinforce anticipatory anxiety or avoidance 
and increase health-related fear or hypervigilance regarding threatening bodily symptoms [6,7]. 
Cognitive behavioural models predict that such factors maintain health anxiety and panic [8]. 
Individuals with asthma and anxiety, in turn, tend to over-perceive symptoms of asthma and 
overreact during asthma episodes, resulting in increased medication and healthcare use [9-11]. 
Strategic planning and clinical guidelines [12-14] recommend the provision of psychological 
interventions for individuals with asthma experiencing complications related to anxiety. 
However, policy reports also highlight that the evidence regarding the usefulness of 
psychological interventions in this context is equivocal [e.g., 15]. 
Whilst some reviews have examined the effectiveness of psychological interventions in 
enhancing asthma-related outcomes more broadly, none have as yet focused specifically on the 
effectiveness of such interventions in improving anxiety in individuals with asthma. For 
example, a meta-analysis by Devine [16] indicated that psycho-educational interventions with 
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adults had benefits across a range of asthma-related outcomes, including amongst six studies that 
used measures of psychological wellbeing. Smith and colleagues [17] reviewed the impact of 
psycho-educational interventions in improving outcomes for adults and children with asthma, 
finding some evidence of reduced hospital admissions, but with mixed findings for other 
outcomes, including anxiety. 
More recently, two Cochrane reviews examined the effectiveness of psychological interventions 
in improving asthma-related outcomes in adults and children respectively [18,19]. These reviews 
primarily focused on health care utilisation, with improving psychological functioning, including 
anxiety, as a secondary outcome. Those studies which considered anxiety outcomes were split 
across a range of intervention and measurement types and the authors were unable to draw firm 
conclusions due to the lack of good quality evidence. 
Evidence supports the effectiveness of cognitive behavioural therapies (CBT) in improving 
anxiety in individuals without a medical comorbidity [20,21] and in reducing anxiety within 
other chronic respiratory conditions, such as chronic obstructive pulmonary disease [22]. 
However, our examination of the literature did not reveal reviews to date that examined the 
effectiveness of CBT for anxiety in individuals with asthma, whilst several studies indicate 
limited support for this model improving psychological functioning in the context of asthma [23-
28]. Given the consistent observations of how these two conditions exacerbate one another and 
reduce the effectiveness of respective treatments and the number of avoidable complications 
related to their interaction [6,7,29-31], it is considered important to examine whether a well-
established psychological intervention for anxiety, CBT, is effective in this context and which 
treatment components would most helpful. 
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Most studies included in the relevant Cochrane reviews [18,19] involved broadly defined 
psychological techniques, such as biofeedback or relaxation, to address the physiological 
symptoms of anxiety, without targeting other aspects of the phenomenology of anxiety or the 
factors that psychological research has identified to maintain it (e.g., cognitive or emotional 
factors or safety-seeking behaviours) [32]. Only three CBT trials that evaluated anxiety 
outcomes met standards for inclusion in the relevant adult Cochrane review and one in the child 
review [18,19]; with some positive outcomes, but not enough to evidence the effectiveness of 
this treatment mode for anxiety. These reviews did not include other study designs, such as non-
randomised, quasi experimental studies, although given the limited number of good quality 
randomised controlled trials (RCTs) in this field, the inclusion of other study designs may help 
address whether CBT is effective with anxiety in asthma populations. In addition, a further 
analysis of the components of each trial may allow for an explanation regarding the limited and 
often contradictory outcomes in this field. 
Aim 
To systematically evaluate the effectiveness of cognitive-behavioural interventions in reducing 
anxiety in adults and/or children and adolescents with asthma. 
Methods 
Search strategy 
The systematic search was conducted in July 2014 and updated in January 2017. Initially, the 
Cochrane database was searched to explore relevant systematic reviews in the field and ensure 
that no similar review was recently undertaken. Subsequently, the following databases were 
searched: Ovid Medline (1946-2014), PsycINFO (1806-2014) and Embase (1974-2014). Terms 
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used to search for keywords in all fields included: CBT or cognit* therap* or behav* therap* or 
cognitive-behav* therap* or problem-solving therap* and anx* and asthma*. 
Manual searches were also undertaken to reduce potential limitations associated with the 
selection of these keywords. All references in the originally identified studies and the relevant 
Cochrane reviews [18,19] were examined. Moreover, publications which subsequently cited the 
included studies, as they appear in the Google Scholar search engine, were also screened. Key 
journals in the field were further searched. To address publication bias, web searches and 
searches in citations of included papers for unpublished documents, conference presentations and 
dissertations were also conducted. Key authors (e.g., Lehrer, Grover) were contacted to suggest 
relevant work. 
Inclusion and exclusion criteria 
Guidance from the Centre for Reviews and Dissemination [33] and the PRISMA statement [34] 
was followed to conduct and report the current review. Inclusion and exclusion criteria were 
based on the ‘PICOS’ approach: population, interventions, comparators, outcomes and study 
design [33]. 
Population 
Included studies had participants with a diagnosis of asthma. No limitations were set on the 
severity of asthma symptomatology or on the diagnostic method/criteria. All types and levels of 
severity of anxiety symptomatology at baseline were included. Studies involving populations 
with other chronic medical/respiratory/mental health conditions were eligible, if results for 
asthma and anxiety were presented separately. No age, gender or other limitations on the 
included population were stipulated. 
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Intervention 
Included studies examined CBT interventions that involved both cognitive and behavioural 
components as defined by Butler and colleagues in their review of the empirical status of CBT 
[35]. Therefore, studies examining the effectiveness of behavioural only interventions, e.g., 
progressive muscle relaxation, were not included. Anxiety improvement was a primary or 
secondary treatment goal in all studies. All CBT intervention formats were eligible (e.g., 
individual and group treatment protocols, computerised or self-help interventions). No 
exclusions were set based on the level of therapist input, length or number of sessions. Studies 
providing additional input to significant others (parents or partners) were eligible. 
Outcome 
Studies were eligible only if severity of anxiety symptomatology was assessed at baseline and at 
post-treatment using a standardised measure (validated observation, interview protocol or self-
report tool). 
Study design and comparators 
Despite the generally higher quality of empirical support provided by randomised controlled 
trials [36], other study designs were also included due to the restricted number of high quality 
RCTs in this field. Thus, non-randomised controlled trials and observational repeated-measures 
designs without controls were also included. Case studies were not included. No restrictions 
were set for the nature of control conditions e.g., treatment as usual, wait-list, placebo controls 
were all included. 
Quality criteria 
The methodological quality of the eligible studies was assessed using quality criteria adapted for 
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the purposes of this review (Table 1). Several authors suggest modifying available quality 
criteria to ensure that they address the requirements of specific review questions [37,38]. 
Existing criteria and guidelines were consulted to assist in developing quality criteria to meet the 
aims of this systematic review, including the SIGN 50 Checklist [39], the consolidated standards 
of reporting trials [40] and the guidance from the Centre for Reviews and Dissemination [33]. 
The ratings of each quality criterion were classified as either: well covered (3 points), adequately 
addressed (2), poorly addressed (1) or not addressed (0). As providing summed scores of quality 
criteria can be misleading, because the criteria are not truly equally weighted, the final rating was 
given as ++, + or -, based on whether the overall rating ranged above 75% (27-36), above 50% 
(18-26) or below 50% (0-17) of the highest possible rating. All studies were rated by the first 
author (EP) and a random sample of five studies was second-rated by the second author (PGM). 
Results 
Study inclusion 
The electronic database search yielded 1721 results and manual searches indicated 83 potentially 
relevant articles. Once the initial electronic database search was completed, duplicates were 
removed and remaining papers were screened against the eligibility criteria. Figure 1 presents the 
search pathway and reasons for exclusion of reviewed studies. One paper was irretrievable [41], 
despite library requests and attempts to contact the author. Fourteen studies met inclusion 
criteria. One paper [7] described two separate trials, each of which independently met the 
eligibility criteria. 
Quality assessment 
All studies were rated based on the quality criteria purposefully developed for this review (Table 
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1). The second author independently evaluated the quality of a randomly selected third (n = 5) of 
included studies using a sequence generated by random.org. This yielded agreement on 50/60 
ratings (83.3%). Disagreement of more than one point was found in four ratings, with these 
discrepancies discussed between raters, and the criteria amended as necessary to increase clarity 
and consistency. 
General characteristics of the studies 
Key characteristics of studies included in this review are provided in Tables 2 and 3. Twelve 
studies involving adult participants (aged 18+) are presented and analysed separately from the 
four studies recruiting children and adolescents. Overall, study quality was moderate, with 
substantial variation amongst included trials. Methodological issues deemed particularly 
pertinent to addressing the review questions included: study design, sample power and 
representativeness, suitability of the intervention and the data collection methods. 
Studies with adults 
Study design 
Of the twelve trials involving adult participants, eight were RCTs, one was a non-randomised 
controlled trial and three uncontrolled repeated-measures designs (Table 2). Five of the RCTs 
were allocated the highest rating (++) [23,24,42-44] due to clearly outlined and appropriate 
randomisation methods. All reviewed studies had methodological limitations in relation to the 
current review question (Table 1). 
Sample representativeness and power 
Of the trials that reported descriptive statistics (Table 2), the mean age of participants ranged 
between 21.7 and 51.9 years. Sample sizes ranged between 10 and 93 participants in the 
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intervention condition. Attrition rates for the intervention groups were moderate overall (≤40%), 
but ranged between 0%-50%. 
Most trials (n = 11) adopted suitable analyses to examine effect over time and differences 
between conditions. Seven studies had not outlined a power calculation and others had 
calculations based on varying assumptions of effect size. Consequently post-hoc power analyses 
were conducted for pre-post results of the intervention group of each trial (for reasons of 
consistency across studies) to inform our quality criteria on sample size / power. These were 
calculated using the G*power programme, estimating effect size to be medium (d = 0.5 for t-test; 
f = 0.25 for ANOVA) and alpha 0.05. 
Most of the reviewed studies (n = 11) achieved power of less than 0.8. Campbell-Sills and 
colleagues [23] achieved the highest rating in terms of sample power for their analysis. Their 
overall sample representativeness and suitability, however, was rated as adequate, due to not 
examining the severity of the included medical conditions and not excluding mental health co-
morbidities for the selection of appropriate participants, which is likely to dilute outcomes. 
Recruitment methods and eligibility criteria varied substantially between the reviewed studies. 
Two studies used convenience samples of inpatients admitted in a single department at the time 
of the study [25], or volunteer college students who were telephone screened for asthma [26], 
without applying any other specific criteria that would allow generalising conclusions based on 
their outcomes. The remaining studies were based on representative respiratory populations 
recruited by multiple specialist services, chronic disease registers, or primary care services, who 
had a physician-confirmed asthma diagnosis. Of the twelve adult trials, eight focused upon 
participants with evidence indicative of clinical levels of anxiety at baseline, using validated 
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methods, e.g., scoring above the clinical threshold for HADS or the Anxiety Disorders Interview 
Schedule for DSM-IV [7a,7b,23,24,42-45]. These were rated higher on quality criteria relating to 
recruitment and inclusion criteria. 
Data collection 
Hockemeyer and Smyth [26] used a robust measure for anxiety, but it was rated poorly as the 
administration instructions asked participants to rate their anxiety over the treatment period, 
rather than the post-treatment period. All other studies used at least one well-validated and 
reliable anxiety measure and administered it appropriately; for example, the HADS [46] and/or 
the anxiety subscale of the ASC [47]. Ten studies reported follow-up outcomes. 
Treatment integrity 
Six interventions were delivered in a group and four in an individual format (Table 2), offering 
from 3 to 14 therapist sessions. Two studies offered a minimum number of either one [23] or no 
therapist sessions [26]. 
Intervention integrity referred to both therapist experience and protocol adherence. Considerable 
variation existed between the background training and clinical experience of therapists, which 
was only reported in eight of the trials. This ranged from clinical or health psychologists and 
CBT therapists [42,44,48] to doctoral nurses [24], psychologists and psychology researchers 
[25,27] or counsellors [45]. Where therapist experience was not extensive, but suitable training 
was provided on the treatment protocol, intervention integrity was rated as high [i.e., 43]. 
Examination of adherence to treatment protocol was sufficiently addressed only by Parry and 
colleagues [42], Feldman and colleagues [43] and Ross and colleagues [24]. 
Eight of the interventions were designed to reduce anxiety as their primary aim [7a,7b,23-25,42-
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44]. Three of the included trials provided minimal or no asthma-related education [23,26,45]. 
Two studies were rated lower regarding the suitability of the protocol for improving anxiety 
outcomes, as they mainly focused on improving asthma knowledge or management and 
addressing asthma health perceptions [27,45]. Of the 12 trials, only six were highly rated 
regarding the dose of CBT provided and the suitability of the protocol [7a,7b,24,42-44]. 
Key findings from adult studies 
Three trials were excluded from consideration [7a,7b,45], as their methodological ability to 
address the review question was rated as relatively low and it would, thus, be less reliable to 
draw conclusions based on their outcomes. A further four studies were with asthmatic patients 
that were not recruited on the basis of also having clinical levels of anxiety [25-27,48]. 
The remaining five studies were with participants with clinical levels of anxiety and had stronger 
overall methodology in relation to addressing the review question. Of these, three found a 
positive effect of CBT on reducing anxiety relative to usual care or wait-list [24,42,44], with two 
reporting statistically significant outcomes [24,42]. Yorke and colleagues [44] recruited 
participants with severe asthma symptomatology, which may explain their lack of statistically 
significant outcomes. 
Feldman and colleagues [43] found statistically significant reductions in anxiety scores over time 
in their CBT group, though their control music and relaxation therapy group also had significant 
reductions in anxiety over time, such that group x time interactions were not statistically 
significant in their modest sample. Their control intervention has previously been reported to 
have positive effects in the context of asthma [49] and thus the absence of an interaction may 
partially reflect genuine benefits of the control intervention. Campbell-Sills and colleagues [23] 
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found no significant differences between treatment as usual and computer-assisted CBT. The 
lack of effect in Campbell-Sills and colleagues [23] may be due to the lack of asthma-related 
input in their intervention (as this was part of a larger scale study examining several medical co-
morbidities) or the lower intensity of their computerised CBT intervention, which may have been 
insufficient to enable improvements in anxiety complicated by asthma. 
All the studies that reported beneficial effects of CBT in reducing anxiety incorporated asthma-
related education alongside or within the CBT intervention, suggesting that asthma-related 
education may be important in enabling reductions in anxiety complicated by asthma. 
Studies with children and young people 
Study design 
Only four trials involving children or adolescent participants met criteria for inclusion in this 
systematic review, of which one was an RCT [28], one was a non-randomised controlled trial 
[50], and two utilised repeated-measures designs [51,52]. The latter two were rated as 
significantly more limited, whereas the RCT and controlled trial, were rated as providing 
similarly strong evidence in relation to the review question (Table 1). 
Sample representativeness and power 
The age of participants ranged between 7 to 14.2 years, with sample sizes for the intervention 
condition of between 17 and 48 participants (Table 3). Aside from Marriage and Henderson [52], 
all other studies had relatively low attrition rates (0%-20%) for the treatment group and adopted 
suitable analyses in relation to addressing the review question. Colland [28] and Papneja and 
Manassis [50] were rated high for achieving a power of at least 0.8 for pre-post analyses, based 
on estimating medium effect size and using an alpha of 0.05. 
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Of the four studies with children and young people, only Papneja and Manassis [50] focused on 
those with evidence of clinical levels of anxiety at baseline, with participants in their study 
meeting criteria for at least one DSM-IV anxiety disorder. Despite their overall high rating, 
sample representativeness in Colland [28] was only adequately addressed as their recruitment 
criteria were based on coping skills rather than anxiety symptomatology. Long and colleagues 
[51] utilised a representative respiratory sample, but did not assess clinical need for anxiety 
intervention at the recruitment stage. Marriage and Henderson [52] recruited asthmatic 
participants, who were assessed to have health-related anxiety by a doctor, although their anxiety 
levels were below clinical levels at baseline. Representativeness in this study was also limited by 
recruitment from a single respiratory clinic. 
Data collection 
All reviewed studies with children and young people used well-validated primary anxiety 
measures. Two studies assessed the outcomes of the intervention up to six and 12 months later 
(Table 3). 
Treatment integrity 
Two trials examined CBT in group formats and one in individual format (see Table 3). One 
study provided the intervention in both formats, but reported their combined results, due to their 
outcomes not being significantly different between conditions [50]. Half of the trials involved 
some level of participation of significant others in treatment [28,50]. The number of offered 
sessions ranged between six and 12. All interventions were facilitated by therapists of varied 
training and experience, from psychologists, psychiatrists and psychotherapists [28,50] to 
graduate therapists, MSc clinicians or research assistants [51], and a respiratory nurse [52]. Only 
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one study recorded sessions and rated them independently to ensure adherence to treatment 
protocol [50]. 
Three studies [50-52] were designed to reduce anxiety as one of their primary aims. Two of the 
trials were rated lower on the treatment suitability for improving anxiety outcomes, as their 
protocol content focused mainly on improving asthma knowledge and illness perceptions 
[28,51]. Papneja & Manassis [50] was the only trial not providing asthma-related education. 
Key findings from studies with children and young people 
All four trials reported significant post-intervention reductions in anxiety outcomes following the 
CBT intervention. Two studies were excluded from consideration as their overall methodological 
quality was rated as low (i.e., -) [51,52]. 
Of the two methodologically stronger studies, Colland [28] found that CBT and asthma training 
led to greater improvements in anxiety compared to a single information session for families or 
to no treatment, despite not having selected participants for clinical levels of anxiety. The only 
relative benefits maintained after 6 months were in state anxiety amongst children with relatively 
high levels of baseline anxiety. 
In the study by Papneja and Manassis [50], the control group were matched children with anxiety 
but without asthma. They reported statistically significant improvements in general anxiety in 
both groups, but the intervention was slightly less effective amongst children with asthma. In the 
latter group physiological anxiety increased post-treatment. Their study did not provide details of 
asthma-related education alongside or within the CBT intervention, which appeared to have been 
an important consideration in the adult literature. 
Discussion 
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This systematic review aimed to explore the effectiveness of CBT interventions for anxiety in 
individuals with co-morbid asthma and anxiety. The reviewed studies provide preliminary 
evidence to support the use of CBT for anxiety in the context of asthma for adults, albeit with 
weak effects in relation to active controls. More tentative support for the use of CBT for anxiety 
with children/young people (7-14 years) with asthma was found, due to the lack of high quality 
evidence in the limited number of studies available. 
Half of the reviewed studies used a generic CBT approach, with some merely focusing on 
modifying illness perceptions and asthma knowledge as a way to reduce anxiety in the context of 
asthma. However, cross-national findings indicate that individuals not only experience anxiety 
around their condition, but present with higher risk at developing any anxiety disorder, including 
generalised anxiety disorder or social phobia [53]. The eight studies that were rated higher for 
applying a stronger CBT protocols for anxiety, all reported benefits in reducing anxiety in 
individuals with asthma. 
More recently, this field has shifted towards adapting specific anxiety-based CBT models and 
exploring cognitions or behaviours, which may maintain the high comorbidity between asthma 
and anxiety to enhance them [54-57]. The need to tailor CBT interventions to specific asthma-
related circumstances seems supported by evidence in the current review. Interventions which 
included asthma-related education alongside or within an empirically-validated CBT intervention 
seemed more likely to demonstrate significant beneficial effects of the intervention on anxiety. 
Limitations of reviewed articles and future research 
Five of the included studies did not have control groups, with the remaining studies usually 
having only non-active groups (e.g., waitlist or standard asthma care). Thus, whilst available 
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evidence indicates effectiveness of suitable CBT protocols, when compared with other 
psychological therapies evidence become less definitive [43]. Future studies may consider 
comparing such CBT interventions with other psychological therapies. 
Considerable heterogeneity existed between outcome measures and follow-up data, limiting 
potential for comparisons between studies. Comparisons were also limited by the wide 
differences in the dose of CBT and the diversity of CBT protocols employed, some of which 
primarily focused on modification of asthma behaviours or knowledge, rather than directly on 
specific anxiety beliefs. Future trials may benefit from adapting evidenced anxiety-focused CBT 
interventions, tailoring them to the particular cognitions and circumstances experienced by those 
with co-morbid asthma and anxiety. This may address the weak effect sizes when compared to 
controls and improve outcomes. 
Future studies would benefit from giving greater consideration to protocol adherence and the 
training of therapists, as these were often not well addressed in the reviewed studies, despite 
having consistently been found to impact on psychotherapy research findings [56,58]. 
Recruitment procedures were insufficiently described for a notable proportion of the included 
studies creating difficulties in assessing the suitability of the sample or the intervention. Of the 
sixteen reviewed studies, only eight adult and one of the child studies screened for clinical levels 
of anxiety as part of their eligibility criteria. It is likely that the other studies included individuals 
with lower levels of anxiety, which would inevitably dilute the effect sizes of the intervention. 
Studies which recruited more clinically representative co-morbid anxious samples with asthma 
were more likely to find beneficial effects of CBT. 
Implications for clinical practice and policy 
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The complications of the interplay between asthma and anxiety have been extensively discussed 
in the literature, including overperception of asthma symptoms and overreaction during episodes 
[10,54], increased healthcare use, independently of pulmonary function [6,9], and substantial 
costs for healthcare providers [59]. Strategic planning reports and national guidelines call for 
appropriate interventions to manage this co-morbidity [12,13], whilst highlighting that evidence 
is equivocal [15]. The current systematic review endeavoured to delineate the outcomes of 
diverse and inconclusive research in this field, focusing on CBT interventions as the most 
evidence-based treatment for anxiety in other populations [20,21]. The review provides 
preliminary support for the use of anxiety-focused CBT interventions, particularly those 
incorporating psychoeducation and/or interventions specific to asthma. 
Strengths and limitations of current review 
The current review benefits from the use of quality criteria purposefully adapted to address the 
review question. In common with most reviews, the quality criteria are not truly equally 
weighted and, thus, summed scores across criteria should be considered tentatively, with 
comparisons between studies on individual criteria being more robust. Efforts were taken to 
separately consider key quality criteria and to check that studies summed scores were 
representative of their overall quality. Although the review process included efforts to identify 
unpublished materials, including contacting key authors, internet searches and searches of 
citations of included papers for unpublished documents, conference presentations or 
dissertations, no unpublished studies that met inclusion criteria were identified. The diversity in 
treatment protocols, sampling and outcome measures led to wide heterogeneity amongst trials 
that, together with reported limitations, prevented a meta-analysis. 
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Conclusion 
Inconsistent outcomes of CBT trials in the context of asthma may be due to the diversity of 
treatment protocols and the inclusion of participants in some trials who lack evidence of clinical 
levels of anxiety. Evidence from the methodologically stronger trials provides preliminary 
support for the effectiveness of CBT interventions in reducing anxiety amongst adults with 
asthma, with more tentative support for children/young people with asthma. Further high quality 
research is needed, and studies may benefit from the use of anxiety-focused CBT interventions, 
which are tailored to address the particular cognitions, circumstances and difficulties experienced 
by individuals with asthma. 
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Table 1. Quality ratings of methodological ability to address review question 
  Sample representativeness Allocation bias Data collection Treatment integrity  Attrition Overall 
rating * 
Authors Study 
design1 
Recruitment & 
inclusion 
criteria2 
Sample 
size / 
power3 
Allocation 
process4 
Groups 
similar at 
baseline5 
Robust 
measures
6 
Follow-up 
measures7 
Suitable 
protocol8 
Treatment 
integrity/ 
adherence9 
Appropriate 
analysis/repo
rting10 
Attrition rates 
low & 
comparable11 
Method to address 
missing data12 
Adults 
Feldman et al., 2016 well 
covered  
well 
covered 
poorly 
addressed 
well covered wellcovered wellcovered poorly 
addressed 
wellcovered wellcovered wellcovered wellcovered well covered ++ 
32/3
6 
Parry et al., 2012 well 
covered 
well 
covered 
poorly 
addressed 
well covered well 
covered 
well 
covered 
adequately 
addressed 
well 
covered 
well covered well 
covered 
adequately 
addressed 
well covered ++ 
32/3
6 
Campbell-Sills et al., 
2013 
well 
covered 
adequately 
addressed 
well 
covered 
well covered poorly 
addressed 
well 
covered 
well 
covered 
poorly 
addressed 
adequately 
addressed 
poorly 
addressed 
well 
covered 
well covered ++ 
28/3
6 
Yorke et al., 2016 well 
covered 
adequately 
addressed 
poorly 
addressed 
well covered well 
covered 
well 
covered 
poorly 
addressed 
well 
covered 
adequately 
addressed 
adequately 
addressed 
adequately 
addressed 
well covered ++ 
28/3
6 
Ross et al., 2005 well 
covered 
well 
covered 
poorly 
addressed 
adequately 
addressed 
adequately 
addressed 
adequately 
addressed 
adequately 
addressed 
well 
covered 
well covered well 
covered 
adequately 
addressed 
poorly 
addressed 
++ 
27/3
6 
Sommaruga et al., 
1995 
well 
covered 
poorly 
addressed 
poorly 
addressed 
adequately 
addressed 
adequately 
addressed 
adequately 
addressed 
well 
covered 
adequately 
addressed 
not addressed adequately 
addressed 
well 
covered 
well covered + 
24/3
6 
Put et al., 2003 well 
covered 
adequately 
addressed 
poorly 
addressed 
adequately 
addressed 
adequately 
addressed 
well 
covered 
poorly 
addressed 
poorly 
addressed 
not addressed well 
covered 
well 
covered 
adequately 
addressed 
+ 
23/3
6 
Hockemeyer & Smyth, 
2002 
well 
covered 
poorly 
addressed 
adequately 
addressed 
adequately 
addressed 
well 
covered 
not 
addressed 
not 
addressed 
poorly 
addressed 
not addressed poorly 
addressed 
well 
covered 
adequately 
addressed 
+ 
18/3
6 
Maes & Schloser, 1988 adequately 
addressed 
poorly 
addressed 
poorly 
addressed 
poorly 
addressed 
adequately 
addressed 
well 
covered 
not 
addressed 
adequately 
addressed 
not addressed well 
covered 
not 
addressed 
well covered + 
18/3
6 
Lehrer et al., 2008b poorly 
addressed 
well 
covered 
poorly 
addressed 
not addressed not 
addressed 
well 
covered 
poorly 
addressed 
well 
covered 
not addressed well 
covered 
poorly 
addressed 
not addressed - 
16/3
6 
Lehrer et al., 2008a poorly 
addressed 
well 
covered 
poorly 
addressed 
not addressed not 
addressed 
well 
covered 
poorly 
addressed 
well 
covered 
not addressed adequately 
addressed 
poorly 
addressed 
not addressed - 
15/3
6 
Spurgeon et al., 2005 poorly 
addressed 
poorly 
addressed 
adequately 
addressed 
not addressed not 
addressed 
well 
covered 
adequately 
addressed 
poorly 
addressed 
not addressed well 
covered 
not 
addressed 
poorly 
addressed 
- 
14/3
6 
Children & Young People 
Papneja & adequately well well poorly well well not well well well covered well adequately ++ 
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Manassis, 2006 addressed covered covered addressed covered covered addressed covered covered covered addressed 29/36 
Colland, 1993 well covered adequately 
addressed 
well 
covered 
adequately 
addressed 
well 
covered 
well 
covered 
well 
covered 
poorly 
addressed 
not 
addressed 
adequately 
addressed 
well 
covered 
well covered ++ 
28/36 
Long et al., 2011 poorly 
addressed 
poorly 
addressed 
poorly 
addressed 
not 
addressed 
not 
addressed 
well 
covered 
not 
addressed 
adequately 
addressed 
adequately 
addressed 
well covered well 
covered 
poorly 
addressed 
- 
17/36 
Marriage & 
Henderson, 2012 
poorly 
addressed 
adequately 
addressed 
poorly 
addressed 
not 
addressed 
not 
addressed 
well 
covered 
adequately 
addressed 
well 
covered 
not 
addressed 
not addressed poorly 
addressed 
poorly 
addressed 
- 
14/36 
1 
Study design provides sufficient evidence that the anxiety outcomes are due to the intervention; 
2 
Recruitment method and inclusion criteria are appropriate to ensure a representative and 
suitable sample; 
3 
Sample size (power) is sufficient for analysis relating to pre and post anxiety 
outcomes; 
4 
Allocation process is appropriate to address allocation bias; 
5 
Groups are comparable 
at baseline on key variables (i.e., asthma or anxiety severity, age, gender); 
6 
Measures of anxiety 
are robust, appropriately administered and well-validated; 
7 
Follow-up measures are administered 
to evaluate if effects are maintained long-term; 
8 
Treatment protocol provides a valid CBT 
intervention with suitable levels of therapist input; 
9 
Intervention is appropriately conducted by 
experienced therapists and adherence to protocol is suitably assessed; 
10 
Analysis is appropriate 
for the study aims, measures or design and outcomes are appropriately reported; 
11 
Attrition rates 
are low or comparable to control group; 
12
 Method to address missing data is suitable. 
* Summed totals for quality criteria should be interpreted cautiously as quality criteria are not all 
of equivalent importance in relation to methodological ability to address the review question. 
Comparisons between studies on individual quality criteria are more robust. 
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Table 2. Characteristics and key findings of included studies with adults 
Study Design/ 
Anxiety 
Criteria 
Intervention 
description 
Control Intervention 
Group 
Control 
group 
Anxiety 
measures 
Intervention Group M & SD Pre-
posteffect 
sizes
1
 
(intervention 
group) 
Followup Key findings Key 
limitations 
Quality 
rating 
2
 PreScoreMean(SD) Post 
ScoreMean 
(SD) 
Group A: Studies which focused on participants with anxiety diagnoses and / or above threshold anxiety scores 
Feldman et 
al., 2016 
[43] USA 
RCT  CBT for panic, 
asthma education 
&biofeedback 
music 
and 
relaxation 
therapy 
n = 24 n = 24 PDSS 2.17 (0.16) 1.64 
(0.18) 
d = 0.45 3 months Both groups 
showed 
statistically 
significant 
improvements 
over time on 
anxiety 
measures. No 
statistically 
significant 
differences 
were found 
between the 
CBT and the 
control group 
on the anxiety 
measures 
Small sample size ++ 
 8 individual 
sessions with 
post-doc fellow & 
graduates with 
extensive training 
on protocol 
Mean age = 
43.8 
Mean age = 
42.6 
 2.45 (0.16) 2.3  Increased attrition 
rates 
DSM-IV 
diagnosis 
of PD, 
PDSS 8+ 
Weekly 
supervision 
provided & all 
sessions were 
videotaped to 
assess integrity 
Female 
91.7% 
Female 
95.8% 
ACQ 16.66 (1.21) -0.17 d = 0.93 Mostly female 
participants 
  moderate 
asthma 
79.2% 
moderate 
asthma 
79.2% 
 15.39 (1.34) 10.39 
(1.39) 
  
    ASI-Physical 14.27 (1.37) 12.28 
(1.52) 
d = 4.92  
     3.05 (0.18) 9.46 
(1.58) 
  
    ASI-Social  2.58 
(0.21) 
d = 2.22  
             ASI-Cognitive   d = 3.32  
             BSQ   d = 2.45  
Parry et al., 
2012 [42] 
RCT CBT for standard care n = 50 n = 44  ITT ITT  6 months A 
significantly 
greater 
improvement 
in asthma-
specific 
anxiety was 
found for the 
CBT group as 
compared to 
controls at 
post-
treatment, 
which 
increased at 
6-months 
High drop-out in 
CBT group 
++ 
UK  asthma-
specific fear 
Mean age = 
47 
Mean age = 
43.8 
Panic-fear 
subscale of 
ASC 
24.83 24.19 d = 0.07 No 
statistically 
significant 
differences 
between 
groups were 
found for the 
general 
anxiety levels 
(HADS) 
22% of the CBT 
group were still in 
the clinical range 
for asthma-specific 
fear at post-
treatment 
 8+ on 
HADS-A 
or 28+ on 
ASC-PF 
5-9 
individual 
sessions with 
clinical 
psychologist 
or CBT 
therapist 
Female 61% Female 65%  -8.92 -9.75    
  Treatment 
fidelity 
assessed 
through peer 
supervision 
& session 
recordings 
severe 
asthma = 
39% 
severe 
asthma 
      
    0.38 Anxiety 
subscale of 
HADS 
Completer Completer    
      26.82 23.94 d = 0.32   
      -8 -9.88    
                 Not reported Not reported d cannot be 
calculated 
  
Campbell-
Sills et al., 
2013 [23] 
RCT Stepped care 
with 
computerised 
CBT 
standard care n = 93 
3
 n = 114 
3
 Anxiety 
subscale of 
BSI 
11.06 
3
 (5.77) 5.92 
3 
(4.99) d = 0.96 6, 12, 18 
months 
Significant 
improvements 
on anxiety 
were found in 
both groups 
over time 
Limited data 
available for asthma 
groups (part of 
larger scale trial) 
++ 
US (part of 
larger 
scale trial) 
Minimum 
10-12 
individual 
sessions & 
minimum 1 
intervention 
contact with 
an anxiety 
specialist 
no other 
demographic 
data 
available 
no other 
demographic 
data 
available 
Participants 
with asthma 
had 
significantly 
greater 
reductions in 
anxiety than 
those without 
asthma, 
regardless of 
whether they 
were in the 
intervention 
Mental health co-
morbidities included 
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or usual care 
groups 
      No reported 
therapist training & 
experience 
 Patients 
with 
GAD, PD, 
PTSD 
and/or 
SAD 
     
Yorke et al., 
2016 [44] 
UK 
RCT CBT for 
chronic 
illness, 
relaxation & 
asthma 
awareness 
with trained 
clinical 
psychologists 
standard care n = 23 n = 21 Anxiety 
subscale - 
12.1 (3.8) Not reported d cannot be 
calculated 
16 weeks Greater 
improvement 
was found in 
anxiety for 
the 
intervention 
group as 
compared to 
controls at 
week 16, 
although this 
was not 
statistically 
significant 
Small sample size ++ 
 8 group 
sessions 
Mean age = 
48.6 
Mean age = 
45 
HADs Increased attrition 
Manual provided, 
but no other 
assessment of 
treatment adherence 
reported 
8+ on 
HADS-A 
or HADS-
D 
Manual to 
enhance 
treatment 
fidelity 
Female 65% Female 48%   
  severe 
asthma 
severe 
asthma 
  
Ross et al., 
2005 [24] 
RCT Asthma 
education & 
CBT for 
panic 
wait-list 
delayed 
treatment 
n = 15 n = 10 SPRAS 73.33 31.73 d = 1.86 6 months Statistically greater 
improvements were 
found in panic 
frequency, general 
anxiety & anxiety 
sensitivity for the 
CBT group as 
compared to controls 
Small 
sample size 
++ 
Canada  12 group 
sessions with 
doctoral 
nurses 
Mean age = 
37 
Mean age = 
40 
 -22.42 -22.29  Only the panic 
frequency results 
were maintained at 6-
months. There was no 
difference between 
groups in 
agoraphobic 
avoidance 
Sampling 
restricted to 
females 
 DSM-IV 
diagnosis 
of panic 
disorder 
Session-by-
session 
protocol & 
treatment 
fidelity 
assessed by 
rating 
videotapes in 
relation to 
protocol 
checklists 
Female 
100% 
Female 
100% 
ASI      
   self-rated 
asthma 
severity 
self-rated 
asthma 
severity  
 35.00 (9.52) 21.27 (9.66) d = 1.43   
    (1-10) (1-10) Agoraphobia 
subscale of 
FQ 
     
   Mean = 6.80 Mean = 3.89  14.07 (7.36) 9.80 (8.88)    
     Panic attack 
diary (N in 
14 days) 
  d = 0.52   
                 6.07 (8.33) 0.13 (0.35)    
                   d = 1.01   
Lehrer et al., 
2008 [7] 
Repeated 
measures 
design 
Asthma 
education & 
CBT for 
panic 
none n = 12 none PDSS 2 0.8 d = 1.16 1 & 2 
months 
Significant decreases 
were found on panic 
& general anxiety 
scores at post-
treatment & follow-
ups 
Small 
sample size 
- 
(study b)  8 group 
sessions 
Mean age = 
31 
    PDSS effect sizes 
were large at post-
treatment & follow-
up, but in BAI were 
small to medium at 
post-treatment & 
follow-up 
No control 
condition 
USA DSM-IV 
diagnosis 
of PD 
Session-by-
session 
protocol 
Female 67% ASI 3.1 2.6 d = 0.68  No reported 
assessment 
of treatment 
fidelity or 
therapist 
training & 
experience 
   moderate 
asthma 
      
   pre&post 
data n = 8 
ACQ 2 1.8 d = 0.33   
              BAI 26 20 d = 0.48   
              BSQ 2.7 2.2 d = 0.60   
Lehrer et al., 
2008 [7] 
Repeated 
measures 
design 
Asthma 
education & 
CBT for 
panic 
none n = 10 none PDSS 1.7 0.7 d = 1.01 1 & 2 
months 
Significant decreases 
were found on panic 
& general anxiety 
scores at post-
treatment & follow-
ups 
Small 
sample size 
- 
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(study a)  14 group 
sessions 
Mean age = 
44.1 
    PDSS and BAI effect 
sizes remained large 
at post-treatment & 
follow-up 
No control 
group 
USA DSM-IV 
diagnosis 
of panic 
disorder 
Session-by-
session 
protocol 
Female 60% ASI 3 2 d = 0.19  High 
attrition 
(50%) 
   mild asthma      No reported 
assessment 
of treatment 
fidelity or 
therapist 
training & 
experience 
   pre&post 
data n = 5 
ACQ 1.8 1.5 d = 0.65   
              BAI 25.5 12 d = 1.21   
              BSQ 2.5 1.9 d = 0.72   
Spurgeon et 
al., 2005 
[45] 
Repeated 
measures 
design 
CBT focused 
on health 
perceptions 
& reactions 
none n = 29 Control 
group did 
not complete 
anxiety 
measures 
Anxiety 
subscale - 
HADS 
12.55 9.17 HADS- 
anxiety 
6 months A statistically 
significant 
improvement in 
anxiety was found at 
post-treatment & 6-
month follow-up 
HADS not 
administered 
to the 
control 
group 
- 
UK (part of 
larger 
trial) 
8 group 
sessions with 
qualified 
counsellors 
Mean age = 
51.9 
d = 0.94 No reported 
assessment 
of treatment 
fidelity or 
attrition 
levels 
   Female 64%   
 Baseline 
HADS-A 
indicates 
>8 
 asthma 
severity not 
reported 
  
Group B: Studies which included any asthmatic participants or where it is likely that participants did not have clinical levels of anxiety at baseline  
Sommaruga 
et al., 1995 
[25] 
RCT Asthma 
education & 
CBT 
standard care n = 20 n = 20 STAI - CBA 
2.0 
  d = 0.67 12 
months 
The CBT 
group showed 
statistically 
significant 
improvements 
in anxiety & 
psycho-
physiological 
symptoms at 
12 months, 
which were 
higher in 
comparison to 
the control 
group 
Convenience 
sampling 
+ 
Italy 3-6 
individual 
CBT 
sessions with 
a 
psychologist 
Mean age = 
44 
Mean age = 
51 
 43.2 (10.0) 36.7 (9.1)  Not selected on 
basis of elevated 
anxiety  
  Female 45% Female QPF -- CBA 
2.0 
  d = 0.38 No reported 
assessment of 
treatment fidelity 
  asthma 
severity: 
inpatients 
55%  48.7 (9.3) 45.1 (9.4)  Unclear therapist 
experience 
   asthma 
severity: 
inpatients 
     
Put et al., 
2003 [27] 
RCT Asthma-
specific CBT 
facilitated by 
a workbook 
wait-list n = 12 n = 11 Panic-fear 
subscale of 
ASC 
1.9 (0.6) 1.6 (0.8) d = 0.42 3 months No 
statistically 
significant 
differences on 
the ASC 
panic-fear 
subscale 
between 
intervention 
and control 
groups 
Small sample size + 
Belgium 6 individual 
sessions with 
psychology 
researchers 
Mean age = 
43 
Mean age = 
48 
Not selected on 
basis of elevated 
anxiety No reported 
assessment of 
treatment fidelity 
  Female 42% Female 62% or therapist 
experience 
  mild -
moderate 
asthma 
mild - 
moderate 
asthma 
 
Hockemeyer 
& Smyth, 
2002 [26] 
RCT Four weeks 
of self-help 
CBT with 
relaxation 
tasks & 
20min 
exercises 
writing about 
stressful 
events 
placebo self-
help 
workbook 
n = 27 n = 27 Perceived 
Stress Scale 
Not reported Not reported d = 0.34 none No 
statistically 
significant 
differences in 
PSS levels 
were found 
over time or 
between 
groups 
Convenience 
sampling 
+ 
USA No therapist 
input 
Mean age = 
21.7 
Mean age = 
19.67 
Not selected on 
basis of elevated 
anxiety PSS 
assessed stress 
levels over 
treatment period 
  Female 56% Female 52% No therapist input 
  self-rated 
health (0-6) 
self-rated 
health (0-6) 
No follow-up 
  Mean = 4.48 Mean = 4.63  
Maes & 
Schloser, 
1988 [48] 
Controlled 
trial 
Asthma 
education & 
Rational 
Emotive 
Therapy 
standard care n = 10 n = 9 Dutch STAI 
state anxiety  
54.5 52.8 d cannot be 
calculated 
none A statistically 
greater 
improvement 
in general 
anxiety was 
found for the 
CBT group as 
compared to 
controls, but 
not in state 
anxiety 
during an 
asthma attack 
Small sample size + 
Netherlands 8 weekly 
group 
sessions with 
patients & 
partners, 
facilitated by 
a health 
psychologist 
& other 
health 
no other 
information 
reported 
no other 
information 
reported 
   Convenience 
sampling 
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professionals 
    Dutch STAI 
trait anxiety 
  Not selected on 
basis of elevated 
anxiety Participants 
not randomised in 
groups 
     47.8 40.5 No follow-up or 
assessment of 
fidelity 
Abbreviations: PDSS: Panic disorder severity Scale; ASI: Anxiety Sensitivity Index; ACQ: 
Agoraphobic Cognitions Questionnaire; BSI: Brief Symptom Inventory; BSQ: Body Sensations 
Questionnaire; BAI: Beck Anxiety Inventory; STAI: State Trait Anxiety Inventory; ASC: 
Asthma Symptom Checklist; HADS: Hospital Anxiety & Depression Scale; FQ: Fear 
questionnaire; SPRAS: Sheehan Patient-Rated Anxiety Scale; CBA: Cognitive Behavioural 
Assessment Batteries; QPF: Psycho-physiological symptoms; GAD: Generalised Anxiety 
Disorder; PD: Panic Disorder, PD: Panic Disorder, SAD: Social Anxiety Disorder, PTSD: Post-
traumatic Stress Disorder 
1 
Cohen [60] suggested interpreting effect sizes as small d = .2, medium d = .5, and large d = .8. 
2
 These relate to ratings of methodological ability to address the current review question and do 
not necessarily reflect the study’s ability to address its own study aims. Summed totals for 
quality criteria should be interpreted cautiously as quality criteria are not equally important, but 
those rated ++ are likely to be strongest in addressing the review question. 
3
 Data available following correspondence with author. 
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Table 3. Characteristics and key findings of included studies with children & young people 
Study Design / Intervention 
description 
Control Intervention 
Group 
Control 
group 
Anxiety 
measures 
Intervention Group 
M & SD 
Pre-post Follow Key findings Key 
limitations 
Quality 
rating 
*    
Anxiety 
Criteria 
Pre Post 
Score 
effect sizesa 
(intervention 
group) 
up 
     
 Score Mean 
(SD) 
  
     
 Mean 
(SD) 
   
Group A: Studies which focused on participants with anxiety diagnoses and / or above threshold anxiety score 
Papneja & 
Manassis, 
2006 [50] 
Controlled 
trial 
CBT for anxiety CBT for 
matched 
group 
without 
asthma 
n = 36 n = 36 RCMAS 
total 
anxiety 
45.2 43.5 d = 0.14 none Statistically 
significant 
reductions in 
anxiety for 
both groups at 
post 
treatment. A 
trend towards 
less 
improvement 
in total 
anxiety in 
children with 
asthma as 
compared to 
those without 
asthma was 
found 
No follow-up 
measures 
++ 
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Canada (data from 
larger scale 
trial) 
12 group or 
individual sessions 
with psychiatrists 
or psychologists 
(potential parental 
involvement) 
8-12 
years 
8-12 years  -12.5 -12.3  Physiological 
anxiety 
increased for 
the asthma 
group 
compared to 
the group 
without 
asthma 
 
           
  Session-by-session 
protocol, audio-
taped sessions 
independently rated 
for adherence 
       Intervention 
group 
combined 
group and 
individual 
CBT 
           
 Met criteria 
for at least 
one DSM-IV 
anxiety 
disorder 
 Asthma 
severity 
not 
reported 
No asthma RCMAS 
physiol. 
anxiety 
     
           
          Treatment 
not adjusted 
for asthma 
           
   Gender 
not 
reported 
Matched to 
intervention 
group by 
gender & 
anxiety 
diagnosis 
 8.3 8.5 d = 0.06   
           
      -3.5 -3.7    
Group B: Studies which included any asthmatic participants or where it is likely that participants did not have clinical levels of anxiety at baseline 
Colland, 
1993 [28] 
RCT Self-
management 
asthma training 
& CBT with 
homework 
assisted by 
parents 
control 
group 
n = 48 na = 34; STAI   d cannot be 
calculated 
1, 6, 
12 
months 
Significant 
reductions in 
trait anxiety 
were found at 
post-
treatment in 
the CBT 
group, but 
these did not 
differ 
significantly 
from controls 
at 6 months 
No reported 
assessment of 
treatment 
fidelity 
++ 
D
ow
nl
oa
de
d 
by
 [T
he
 U
niv
ers
ity
 of
 E
din
bu
rg
h]
 at
 03
:58
 01
 Se
pte
mb
er 
20
17
 
ACCEPTED MANUSCRIPT 
ACCEPTED MANUSCRIPT 36 
      Not 
reported 
Not 
reported 
Only a 
reduction in 
state anxiety 
amongst 
extremely 
anxious 
children 
remained 
significant at 
6-months 
 
Netherlands 10 group 
sessions with a 
behaviour 
therapist & a 
group 
psychotherapist 
a: one 
information 
session 
Mean 
age = 10 
nb = 30 state 
anxiety 
   Not selected on 
basis of 
elevated 
anxiety 
          
  b: no 
therapy 
Female 
39% 
Mean age = 10  34.5    
          
    Females 
38.9% 
     
       30.4   
     STAI 
trait 
anxiety 
    
Long et al., 
2011 [51] 
Repeated 
measures design 
Asthma 
education & 
CBT with 
physiological 
feedback & 
relaxation 
none n = 22 none PSS 21.06 12.44 d = 1.65 none Statistically 
significant 
improvements 
were found in 
PSS & 
anxious mood 
at post-
treatment, but 
not for the 
state-trait 
anxiety 
measure 
No follow-up 
measures 
- 
         
USA (two combined 
trials) 
6 individual 
sessions with 
graduate CBT 
therapists, MSc 
clinicians & 
research 
assistants 
(trial 1 n 
= 14 
 -4.84 -5.57  Not selected on 
basis of 
elevated 
anxiety No 
control 
condition 
         
  Session-by-
session 
protocol & 
supervision 
trial 2 n 
= 8) 
    Limited 
therapist 
clinical 
experience 
         
   7-12 
years 
POMS 2.79 1.74 d = 0.60  
         
   Female 
36% 
anxiety -1.78 -1.73   
         
   mild-
moderate 
persistent 
asthma 
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    STAI 
state 
anxiety 
44.33 44.39 d < 0.01  
         
     -13.75 -14.06   
         
    STAI 
trait 
anxiety 
    
         
       d = 0.40  
         
     34.22 31.22   
         
     -7.67 -7.22   
Marriage & 
Henderson 
2012 [52] 
Repeated measures 
design 
Asthma 
education 
& CBT 
with 
mindfulness 
none n = 17 none SCAS 35.2 28.9 d cannot be 
calculated 
3 & 6 
months 
A reduction 
of up to 30% 
on anxiety 
scores was 
found at post-
treatment and 
at 6 months 
Descriptive 
statistics only 
- 
      
UK  6 group 
sessions 
with a 
respiratory 
nurse 
specialist 
trained in 
behavioural 
techniques 
Mean 
age = 
14.2 
(3 mth 
post) 
High attrition 
      
 Diagnosed with 
‘health-related 
anxiety’ but anxiety 
at non-clinical level 
 Female 
50% 
 Convenience 
sample 
      
   mild-
severe 
asthma 
 Baseline 
anxiety levels 
were elevated, 
but not in 
clinical range 
      
     No reported 
assessment of 
treatment 
fidelity 
Abbreviations: STAI: State Trait Anxiety Inventory; POMS: Profile of mood states; RCMAS: 
Revised Children’s Manifest Anxiety Scale; SCAS: Spence Children’s’ Anxiety Scale; PSS: 
Perceived Stress Scale 
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a 
Cohen [60] suggested interpreting effect sizes as small d = .2, medium d = .5, and large d = .8. 
* These relate to ratings of methodological ability to address the current review question and do 
not necessarily reflect the study’s ability to address its own study aims. Summed totals for 
quality criteria should be interpreted cautiously as quality criteria are not equally important, but 
those rated ++ are likely to be strongest in addressing the review question. 
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Figure 1. Flowchart of search strategy pathway and results 
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